IEQ CAPITAL, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 126 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.

Quarter-by-quarter ownership
IEQ CAPITAL, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$265,421
-39.1%
84,5290.0%0.01%
-44.4%
Q2 2023$436,170
-2.1%
84,5290.0%0.01%
-10.0%
Q1 2023$445,468
+13.6%
84,529
-39.4%
0.01%
-9.1%
Q4 2022$392,076
-66.7%
139,529
-50.9%
0.01%
-65.6%
Q3 2022$1,178,000
+3.2%
283,9330.0%0.03%
-8.6%
Q2 2022$1,141,000
-43.5%
283,933
-30.4%
0.04%
-27.1%
Q1 2022$2,019,000
-29.0%
407,9330.0%0.05%
-27.3%
Q4 2021$2,843,000
-54.8%
407,933
-35.1%
0.07%
-60.5%
Q3 2021$6,289,000
-29.5%
628,982
+0.0%
0.17%
-36.3%
Q2 2021$8,918,000
-13.6%
628,9330.0%0.26%
-38.5%
Q1 2021$10,321,000
-20.7%
628,9330.0%0.43%
-26.4%
Q4 2020$13,019,000
+151.9%
628,933
-7.4%
0.58%
+108.3%
Q3 2020$5,169,000
-8.6%
679,2330.0%0.28%
-24.3%
Q2 2020$5,658,000
+346.6%
679,233
+165.3%
0.37%
+259.8%
Q1 2020$1,267,000
+25.3%
256,0450.0%0.10%
+14.6%
Q4 2019$1,011,000256,0450.09%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$19,223100.00%
Opaleye Management Inc. 6,468,000$20,309,5206.61%
DELTEC ASSET MANAGEMENT LLC 2,061,797$6,474,0431.48%
Endurant Capital Management LP 353,707$1,110,6401.00%
SECTORAL ASSET MANAGEMENT INC 969,350$3,043,7590.59%
NOTTINGHAM ADVISORS, INC. 194,266$609,9950.09%
Covestor Ltd 37,404$1170.09%
GSA CAPITAL PARTNERS LLP 233,582$7330.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 342,111$1,074,2290.03%
Polar Asset Management Partners Inc. 263,763$828,2160.02%
View complete list of OCULAR THERAPEUTIX INC shareholders